MediciNova Financials - Benzinga

MediciNova Inc

MNOVNASDAQ

Trade with Public

Trade with Public

$1.44

0.021.41%

Últ. Act.: Aug 28, 1:06 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Comparar Opciones Informe de acciones

MediciNova Financials

MediciNova (MNOV) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
MediciNova Q2 EPS $(0.07) Beats $(0.10) Estimate, Sales $134.599K

MediciNova (NASDAQ:MNOV) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 26.32 percent. This is a 40 percent decrease over losses of $(0.05) per share from the same

Benzinga Newsdesk

PRO
MediciNova Q1 EPS $(0.06) Beats $(0.14) Estimate

MediciNova (NASDAQ:MNOV) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.14) by 57.14 percent. This is unchanged from the same period last year.

Benzinga Newsdesk

The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Shanthi Rexaline

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16)

Shanthi Rexaline

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12)

Shanthi Rexaline

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

Shanthi Rexaline

© 2026 Benzinga | All Rights Reserved